These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31711496)

  • 1. The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB.
    Formicola B; Dal Magro R; Montefusco-Pereira CV; Lehr CM; Koch M; Russo L; Grasso G; Deriu MA; Danani A; Bourdoulous S; Re F
    J Nanobiotechnology; 2019 Nov; 17(1):115. PubMed ID: 31711496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
    Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
    J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
    Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma.
    Zhang Y; Zhang L; Hu Y; Jiang K; Li Z; Lin YZ; Wei G; Lu W
    J Control Release; 2018 Nov; 289():102-113. PubMed ID: 30243823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy.
    Zhan W; Wang CH
    J Control Release; 2018 Sep; 285():212-229. PubMed ID: 30009891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3.
    Qin C; He B; Dai W; Lin Z; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q
    Biomaterials; 2014 Jul; 35(22):5908-20. PubMed ID: 24743031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.
    Sun T; Zhang Y; Power C; Alexander PM; Sutton JT; Aryal M; Vykhodtseva N; Miller EL; McDannold NJ
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10281-E10290. PubMed ID: 29133392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
    Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.
    Qin C; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3233-41. PubMed ID: 24559485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
    Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
    Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide.
    Han M; Xing H; Chen L; Cui M; Zhang Y; Qi L; Jin M; Yang Y; Gao C; Gao Z; Xing X; Huang W
    J Drug Target; 2021 Nov; 29(9):1016-1028. PubMed ID: 33825602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.
    Bana L; Minniti S; Salvati E; Sesana S; Zambelli V; Cagnotto A; Orlando A; Cazzaniga E; Zwart R; Scheper W; Masserini M; Re F
    Nanomedicine; 2014 Oct; 10(7):1583-90. PubMed ID: 24333591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
    Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
    J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipid composition on the properties of doxorubicin-loaded liposomes.
    Sakai-Kato K; Nanjo K; Kawanishi T; Okuda H; Goda Y
    Ther Deliv; 2015 Jul; 6(7):785-94. PubMed ID: 26228772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.
    Grange C; Geninatti-Crich S; Esposito G; Alberti D; Tei L; Bussolati B; Aime S; Camussi G
    Cancer Res; 2010 Mar; 70(6):2180-90. PubMed ID: 20215497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.